The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia
- PMID: 23616916
- PMCID: PMC3627322
- DOI: 10.1177/2040620712453596
The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia
Abstract
Romiplostim is a thrombopoietin peptide mimetic agent recently approved for the treatment of adults with chronic immune thrombocytopenia (ITP). In randomized controlled studies, this agent has demonstrated an increase in the platelet count in the majority of patients with ITP, both in splenectomized and nonsplenectomized patients. In up to 5 years of follow up, its safety profile has been favorable, suggesting this could be a novel therapeutic agent in patients with ITP. This article summarizes the development of this new agent and explores its safety and efficacy in adults with chronic ITP.
Keywords: AMG-531; immune thrombocytopenia; romiplostim; thrombopoietin; thrombopoietin-mimetic agents.
Similar articles
-
Romiplostim: a review of its use in immune thrombocytopenia.Drugs. 2012 Feb 12;72(3):415-35. doi: 10.2165/11208260-000000000-00000. Drugs. 2012. PMID: 22316355 Review.
-
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Haematologica. 2017 Aug;102(8):1342-1351. doi: 10.3324/haematol.2016.161968. Epub 2017 Apr 14. Haematologica. 2017. PMID: 28411254 Free PMC article. Clinical Trial.
-
Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Ther Adv Hematol. 2012 Jun;3(3):155-64. doi: 10.1177/2040620712442525. Ther Adv Hematol. 2012. PMID: 23556122 Free PMC article.
-
Romiplostim in chronic immune thrombocytopenic purpura.Clin Ther. 2009 Sep;31(9):1887-907. doi: 10.1016/j.clinthera.2009.09.013. Clin Ther. 2009. PMID: 19843480 Review.
-
Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.Immunotargets Ther. 2016 Feb 22;5:1-7. doi: 10.2147/ITT.S80648. eCollection 2016. Immunotargets Ther. 2016. PMID: 27529057 Free PMC article. Review.
Cited by
-
Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.Case Rep Hematol. 2015;2015:583451. doi: 10.1155/2015/583451. Epub 2015 Jun 9. Case Rep Hematol. 2015. PMID: 26180646 Free PMC article.
-
Pharmacokinetics, Safety, and Pharmacodynamics of Romiplostim in Chinese Subjects With Immune Thrombocytopenia: A Phase I/II Trial.Clin Pharmacol Drug Dev. 2022 Mar;11(3):379-387. doi: 10.1002/cpdd.1059. Epub 2021 Dec 17. Clin Pharmacol Drug Dev. 2022. PMID: 34921514 Free PMC article. Clinical Trial.
-
Persistent Immune Thrombocytopenia Resistant to Immunosuppressive Therapy: What Is the Way Forward?Cureus. 2020 Dec 30;12(12):e12377. doi: 10.7759/cureus.12377. Cureus. 2020. PMID: 33527058 Free PMC article.
-
Extreme Thrombocytosis in Refractory ITP Post-Splenectomy With Associated Fatal Thromboembolism.Clin Pathol. 2022 Mar 4;15:2632010X221083218. doi: 10.1177/2632010X221083218. eCollection 2022 Jan-Dec. Clin Pathol. 2022. PMID: 35284824 Free PMC article.
References
-
- Branehog I., Kutti J., Weinfeld A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol 27: 127–143 - PubMed
-
- Branehog I., Weinfeld A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scand J Haematol 12: 69–79 - PubMed
-
- Broudy V., Lin N. (2004) AMG 531 stimulates megakaryopoiesis in vitro by binding to MPL. Cytokine 25: 52–60 - PubMed
LinkOut - more resources
Full Text Sources
Medical